|
Organon International offers health and wellness to man and beast alike. The company's Organon business emphasizes women's health pharmaceuticals, including contraception, hormone replacement, and treatments for infertility, and osteoporosis. Its Intervet business focuses on animal health, while its Nobilon unit develops human vaccines. The company's Diosynth business offers third-party manufacturing services of biotech proteins. Founded in 1923 and co-headquartered in the US and The Netherlands, Organon International was acquired by Schering-Plough in 2007.
|
| | | Contact Information | |
Address: |
Molenstraat 110
5340 BH Oss, The Netherlands
| | Phone: | +31-412-66-1222 | | Fax: | +31-412-66-2617 |
|
| Financial
Highlights | | Fiscal Year End: | December |
|
|
Key People
| | • |
President:
A.T. M. (Toon) Wilderbeek
| | • |
CFO:
Jörg Spiekerkötter
| | • |
EVP Corporate Development:
Geert van Alphen
|
|
|
